packageSamarium153SmLexidronam

samarium (153Sm) lexidronam

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Samarium (153Sm) lexidronam is a radiopharmaceutical used to relieve pain from cancer that has spread to the bones. It is an approved medicine, with one product authorised in the European Union, and is used for bone pain palliation.

Summary written by glm-5.3-flash from Wikidata Q20817238 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:samarium (153Sm) lexidronam
ATC codes:V10BX02
DrugBank:DB05273
Wikidata:Q20817238
molar mass:586.02 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown